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ATGL-1 AND LONGEVITY IN C. ELEGANS 
AYOMIDE SEMMY ADELEKE 
ABSTRACT 
 Obesity and obesity related diseases represent a leading cause of mortality in the 
United States and worldwide. Our research is oriented towards the role of lipid 
metabolism in longevity. Adipose triglyceride lipase, or ATGL, is a rate limiting enzyme 
in the lipolytic pathway. The nematode, C. elegans has many conserved biologic 
pathways to mammals, and the lipolytic pathway is one of them. The homologues include 
the insulin receptor (DAF-2), FoxO1 (DAF-16), and ATGL (ATGL-1).  
In this study, we use C. elegans as a model to study the role of lipolysis in 
longevity. It has been previously shown in our lab that overexpression of ATGL-1::GFP 
increases lifespan. To confirm that the increase in longevity was due to the 
overexpression of ATGL-1, we have used RNA interference to downregulate expression 
of ATGL-1::GFP. We have corroborated that ATGL-1::GFP worms have longer 
lifespans, than wildtype N2 worms.  
We have also found that RNAi control diet does not affect lifespan of ATGL-
1::GFP strains. However, ATGL-1::GFP strains on an RNAi GFP diet demonstrate 
reduced levels of ATGL-1::GFP and have shorter lifespans compared to their control 
counterparts. Our findings confirm that overexpression of ATGL-1 increases lifespan of 
C. elegans probably due to its role in reducing fat content. 
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INTRODUCTION 
Lipolysis Mediated Control of Longevity 
 Aging is a degenerative biological process characterized by the deterioration of 
cellular integrity. There are several different environmental and metabolic components 
that lead to accelerated aging resulting in premature mortality. Obesity and excessive fat 
accumulation have been shown to decrease longevity in both human and model organism 
studies. Not only is obesity associated with accelerated onset of ageing and metabolic 
disease, but removal/ablation of fat as well as mutations affecting fat mass have been 
shown to increase life span and rates of mortality21. It has been previously shown that 
surgical removal of visceral fat extends life span in mice11.  
Adipose triglyceride lipase, or ATGL, is a rate limiting enzyme in lipolysis, the 
process that breaks down triglycerides in fat cells both basally and during periods of 
fasting and limited nutritional availability7. The lipolytic pathway begins with the 
hydrolysis of triglycerides via tri-, di-, and mono-acylglyceride lipases, releasing a free 
fatty acid during each step and resulting in a free fatty acid and glycerol. ATGL 
expression is regulated by upstream targets FoxO1/Sirt1 and/or mTOR. Currently, these 
two known biological pathways (mTOR and FoxO1) that control longevity converge at 
the regulation of ATGL expression. It has been previously shown that ablation of ATGL 
caused obesity while overexpression of ATGL resulted in a slimming phenotype22. 
Linking these two theories, we hypothesize that ATGL may be the downstream FoxO1 
target responsible for the extension of lifespan.  
The FoxO family of TFs are involved in cell cycle regulation/cell growth, stress 
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resistance, tumor suppression, and metabolism19. FoxO1 has been shown to increase rates 
lipolysis by activating ATGL7. mTOR is involved in cellular proliferation/growth, 
metabolic regulation, and protein synthesis16. Its role in lipolytic control converges at the 
level of suppression of ATGL20.  It has been tested and reported that elevated ATGL 
expression increases both basal and cAMP-initiated lipolysis, controlled by insulin14. 
Energy balance is in part controlled by lipolysis by maintaining the size of lipid deposits 
in tissue. So, upregulation of ATGL breaks down triglyceride stores and therefore may 
increase longevity by reducing fat content. These findings lead to the exploration of a 
potential connection between ATGL and longevity. 
Free fatty acids released from adipocytes in lipolysis are transported to other 
tissues where they can be used for energy production through fatty acid oxidation. Insulin 
plays a major role in inhibiting lipolysis to promote triglyceride storage in fat cells. 
Excess accumulation of lipids in non-adipose tissue can lead to lipotoxicity resulting in 
adverse effects to cells including insulin resistance, pancreatic β-cell apoptosis and heart 
failure12. In people with type 2 diabetes and insulin resistance, insulin can no longer 
function properly resulting in high levels of FFA in the bloodstream and accumulation of 
FFA in non-adipose peripheral tissues. This lipotoxicity aggravates insulin resistance 
leading to a feedback loop of adverse metabolic dysfunction. Excess FFA can also lead to 
high VLDL levels resulting in predisposition to cardiovascular injury and disease.7 
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C. Elegans as a Model for Longevity Studies 
Lipid droplets are evolutionary conserved organelles across many different 
species including mammals, drosophila, and C. elegans. In C. elegans, fat is stored in its 
intestines even though the species lack defined adipose tissue. Their intestines can 
support lipid droplets as large as sizes seen in mammalian adipocytes. Sequencing of C. 
elegans’ genome show conservation of genes involved in lipolysis and fatty acid 
synthesis as well as conservation of important signaling pathways such as insulin, mTOR, 
and TGFβ.2 Furthermore, C. elegans offer a model opportunity to study changes to fat 
storage and whole organism physiology and lifespan. 
C. elegans is a model organism for longevity studies. These nematodes express 
the insulin receptor and subsequently have evolutionary homologues of the FoxO1/Sirt1 
pathway13 as shown in Figure 1. The homologues include the insulin receptor (DAF-2), 
FoxO1 (DAF-16), and ATGL (ATGL-1). In addition to the conserved metabolic 
pathway, C. elegans lifespan experiments generally last only 2–4 weeks. N2 worms 
typically have an average lifespan of ~20 days and are used as the wildtype group for 
most longevity studies. ATGL-1::GFP worms are the mutant transgenic strains that have 
overexpressed levels of ATGL-1 and have an average lifespan of ~28 days. C. elegans 
have naturally auto-fluorescent lysosomal organelles, however using fluorescent 
microscopy and linear unmixing it has been shown that ATGL-1::GFP are distinct and 
distinctly localized to the surface of lipid droplets in both wild type and mutant 
animals.3,4 An advantage of using C. elegans as a model for this type of research is the 
ability to apply gene manipulation and inactivation via RNAi.  
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RNAi 
RNA interference is a term used to describe dsRNA blocking gene expression 
through posttranscriptional mRNA degradation. It was originally observed in worms and 
later discovered in a variety of animals including mice, drosophila, zebrafish, etc1. RNAi 
has been used to create phenotypic copies of loss of function mutations and can be used 
to determine loss of function genes in C. elegans. It has also been investigated in 
therapeutic intervention to parasites and pathogens. RNAi is a conserved biological 
response and can be triggered via endogenous triggers such as foreign viral DNA or 
dsRNA, repetitive sequences such as transposons, or pre-miRNA. 
RNAi can be induced through microinjection, feeding, or soaking5. Through the 
feeding method, which was the method used in this experiment, dsRNA is transcribed in 
E. coli and ingested by the worms through a feeding protocol. The RNAi is prepared and 
seeded onto NMG plates and induced through an inducible factor, IPTG. IPTG is 
required to induce the expression of genes cloned downstream the T7 promoter. Thus, 
HT115 (DE3) strains of bacteria were used. These strains carry the gene that encodes for 
the T7 RNA polymerase and lack RNase III making them deficient in degrading 
dsDNA5,6. In this study we used RNAi via feeding to genetically downregulate GFP in 
ATGL-1::GFP C. elegans.
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METHODS 
RNAi Bacteria 
 
 To induce the RNAi downregulation of GFP, IPTG was used to prepare bacterial 
strains of E. coli. E. coli are gram negative bacteria. OP50 is the regular feeding strain of 
bacteria, however we used competent HT115 (DE3) strains of bacteria in order to ensure 
inducible expression of the phage T7 RNA polymerase. OP50 bacteria is not antibiotic 
resistant while the HT115 (DE3) strain is. The antibiotics used in our protocol to grow 
the bacteria, induce RNAi phenotypes and the rate of bacterial growth. Furthermore, 
tetracycline is used to suppress gene expression and induces the downregulation of the 
gene of interest, which is GFP in this case. This occurs through the regulation of the 
tetracycline operator (tetO)23. Under basal conditions, without the presence of Tet, the 
tetracycline activator (tetA) binds to the operon, promoting gene expression. In the 
presence of tetracycline, the repressor portion of tetA binds to tetracycline instead of the 
operator, reducing gene expression. The use of antibiotics can also prevent bacteria that 
do not express the plasmid and non-antibiotic resistant strains of bacteria from growing 
and therefore serves to protect against certain types of contamination.  
From this, four groups were generated and examined: N2 RNAi Cont (N2 control 
worms on control bacterial diet), N2 RNAi GFP (N2 control worms on dsRNA GFP 
downregulation bacterial diet), ATGL-1::GFP RNAi Cont (ATGL-1::GFP experimental 
worms on control bacterial diet), and ATGL-1::GFP RNAi GFP (ATGL-1::GFP 
experimental worms on dsRNA GFP downregulation bacterial diet). N2 worms were 
used to ensure that the bacterial cultures had no effect on their lifespan. Since N2 worms 
	6 
lack ATGL-1::GFP, their lifespan should not significantly differ on either diet and the 
RNAi GFP diet should not have an effect on fluorescence. ATGL-1::GFP worms express 
ATGL-1 and therefore have a longer average lifespan than those that do not express 
ATGL-1 or where ATGL-1 is downregulated. Each group contained 10 plates of 20 
worms per plate (N=200 worms per group).  
Nematode Plate Preparation for RNAi Feeding 
 Using the standard NGM recipe, (3 g of NaCl, 2.5 g of peptone, and 20 g of agar 
and bring to 1 L with H2O; liquid autoclave for 1hr and let cool; 1 mL of cholesterol [5 
mg/mL in ethanol], 1 mL of 1 M CaCl2, 1 mL of 1 M MgSO4, and 25 mL of 1 M [pH 
6.0] KPO4) plus an additional 50µg/mL Amp, 12.5µg/mL Tet, and 0.4mM of IPTG, I 
prepared 3.5L for ~300 RNAi plates. Plates were prepared at the beginning of each 
experiment and were used throughout the experiment as necessary. A single colony of 
bacteria was inoculated in liquid LB medium, containing 100µg/mL Amp, 12.5µg/mL 
Tet, incubated overnight with shaking at 37C, and grown to OD595=0.4. Bacteria was 
then induced by adding 0.4mM of sterile IPTG and incubated with shaking at 37C for 4 
hours. Before plating, another 100µg/mL Amp, 12.5µg/mL Tet, and 0.4mM of IPTG was 
added to the centrifuged and 5x concentrated final volume of bacterial broth. Each RNAi 
plate was seeded with 250µL of 5x concentrated control or experimental bacterial 
cultures. Bacteria was prepared fresh and seeded onto RNAi plates as needed. The sides 
of each plate were marked accordingly with different colors to distinguish between 
control and experimental bacterial cultures. 
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Longevity Experiments 
 To begin the longevity experiment, 2 L4 worms from each strain were picked and 
put  onto regular plates with OP50 bacteria. This was to grow a synchronous generation 
of young adult worms because at this larval stage, these are the worms that bear eggs. It 
takes about 5 days for the worms to reach this age.  30 of these worms from each strain 
were picked and put  onto RNAi plates (RNAi Cont and RNAi GFP) and allowed to lay 
eggs. After 6hrs,  the worms were removed. The eggs from these plates hatched the next 
day, creating a synchronous generation, and that was noted as day 1 of the experiment. 
By day 2, worms were in the L3 stage and the transfer began on that day. 200 worms per 
strain were transferred onto RNAi plates according to their appropriate group. Worms 
were counted and scored daily on plates containing RNAi-expressing bacteria until all of 
the worms on the plate (N= 20 worms per plate) had died or disappeared from the plate. 
All animals were stored daily in 20°C incubator. Worms were moved every 2 days to a 
new RNAi plate until the end of reproductive age was reached. This was to ensure that 
only the original worms were being followed and counted and not any new generation of 
worms. 
Statistical Analysis  
Percent survival was calculated as shown in Figure 2 and Figure 3, accounting 
for the number of live worms, deaths, and censored. Max lifespan is defined as the entire 
elapsed time from day 1, when worms were first put on RNAi plates until when it is 
recorded as dead. Mean lifespan refers to the average age in days of worms still alive at 
50% survival. Worms were scored as dead when they stopped responding to prodding by 
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wired picks. Only natural deaths were recorded; worms that died unnaturally (e.g. eggs 
hatching inside worm, intestines developed outside of body) were removed from the plate 
and were censored. Worms that crawled off the plate/under the agar, exploded, or 
bagged9 were not counted in the analysis as natural deaths and were removed from the 
plate for censorship. This number of worms were censored for statistical analysis. 
To assess mean lifespan, max lifespan, and % difference from N2 control group, 
Online Application for Survival Analysis (OASIS) was used24, 25. All statistics with p-
values are reported in Table 1 and Table 2. 
Microscopy Analysis 
 To ensure RNAi was effective in downregulating GFP, fluorescent microscopy 
was used and measured weekly throughout the experiment as shown in Figures 4, 5, and 
6. Worms were picked and placed on 3% agarose mounted on microscope lens glass. A 
drop of sodium azide was used to paralyze worms for accurate photo taking. All images 
of the same day were taken under the same exposure time and are shown under 20x lens.	  
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RESULTS 
 
 Baseline characteristics of the groups from each experiment are shown in Tables 
1 and 2. In the first experiment, ATGL-1::GFP on a control diet had the longest lifespan 
with an average lifespan of 21.03 (+/- 0.85) days. Followed by N2 fed the control diet 
with an average lifespan of 17.2 +/- 0.52 days, N2 worms fed on the RNAi GFP diet with 
an average lifespan of 16.77 +/- 0.39 days, and ATGL-1::GFP worms fed the RNAi GFP 
diet with an average lifespan of and 15.01 +/- 0.38 days. ATGL-1::GFP worms on the 
control diet had the highest percent difference in lifespan compared to the control group 
(N2 worms on a control diet) at 22.3% (p=0.001). N2 worms on RNAi GFP bacteria did 
not significantly differ from the control group at 2.5% (p=0.70). ATGL-1::GFP worms on 
RNAi GFP bacteria also did not significantly differ from the control group at 12.7% 
(p=0.09).  
The results of the second experiment showed a similar trend, with ATGL-1::GFP 
on a control diet having the longest lifespan with an average lifespan of 20.18 +/- 0.78 
days. Followed by ATGL-1::GFP on the RNAi GFP diet with an average lifespan of 15.6 
+/- 0.42 days, N2 on the RNAi GFP diet with an average lifespan of 15.22 +/- 0.4 days, 
and finally N2 worms on the control diet with an average lifespan of 14.54 (+/- 0.84) 
days. ATGL-1::GFP worms on the control diet had the highest percent difference in 
lifespan compared to the control group (N2 worms on a control diet) at 38.8% 
(p=0.0001). Both N2 and ATGL-1::GFP worms on RNAi GFP bacteria did not 
significantly differ from the control group at 4.7% (p=0.29) and 7.3% (p=0.23), 
respectively. 
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 The percent survival of each strain and treatment in the first experiment is 
displayed in Figure 2. Maximum lifespan for the strains were 26 days (N2 worms on a 
control diet), 25 days (N2 worms on RNAi GFP diet), 33 days (ATGL-1::GFP on control 
diet), and 26 days (ATGL-1::GFP on RNAi GFP diet). The percent survival of each strain 
and treatment in experiment 2 is shown in Figure 3. Max lifespan for the strains were 21 
days (N2 worms on a control diet), 22 days (N2 worms on RNAi GFP diet), 30 days 
(ATGL-1::GFP on control diet), and 24 days (ATGL-1::GFP on RNAi GFP diet).  
The average lifespan for N2 worms is ~20 days while ATGL-1::GFP worms have an 
average survival rate of ~28 days. 
Fluorescent Microscopy as a Method of GFP Analysis 
Fluorescent GFP levels on days 2, 16, and 22 are shown in Figures 4, 5, and 6 
respectively. On day 2 of the experiment, successful downregulation of GFP is shown by 
decreased GFP levels in ATGL-1::GFP worms on the RNAi GFP diet. The GFP 
downregulation continued throughout the experiment, as shown in Figures 5 and 6.  
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Table 1. Experiment #1: Baseline characteristics and statistical analysis of all strains 
and treatment. 
Strain/ 
Treatment 
Sample Size on 
Day 1 
Mean Lifespan 
(Days) 
%  Difference 
from N2 Cont Max Lifespan 
N2 RNAi 
Control N= 200 17.2 +/- 0.52  26 
N2 RNAi GFP N= 200 16.77 +/- 0.39 2.5% (p=0.70) 25 
ATGL-1::GFP 
RNAi Control N= 100 21.03 +/- 0.85 22.3% (p=0.001)* 33 
ATGL-1::GFP 
RNAi GFP N= 180 15.01 +/- 0.38 12.7% (p=0.09) 26 
 
Baseline characteristics including sample size on day one, mean lifespan, percent 
difference from N2 on control diets, and max lifespan are all reported. 
*Signifies statistical significance from the control (N2 worms on a control diet). 
 
Table 2. Experiment #2: Baseline characteristics and statistical analysis of all strains 
and treatment. 
Strain/ 
Treatment 
Sample Size on 
Day 1 
Mean Lifespan 
(Days) 
%  Difference from 
N2 Cont Max Lifespan 
N2 RNAi 
Control N= 200 14.54 +/- 0.85  21 
N2 RNAi GFP N= 200 15.22 +/- 0.4 4.7% (p=0.29) 22 
ATGL-1::GFP 
RNAi Control N= 200 20.18 +/- 0.78 38.8% (p=0.0001)* 30 
ATGL-1::GFP 
RNAi GFP N= 200 15.6 +/- 0.42 7.3% (p=0.23) 24 
 
Baseline characteristics including sample size on day one, mean lifespan, percent 
difference from N2 on control diets, and max lifespan are all reported. 
*Signifies statistical significance from the control (N2 worms on a control diet). 
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Figure 1: Evolutionary conserved lipolytic pathway  
In C. elegans the homologues for the lipolytic enzymes are daf-2 (insulin receptor), daf-
16 (FoxO1), and ATGL-1 (ATGL).  
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Figure 2: Experiment #1 Percent survival of N2 and ATGL-1 control and 
experimental groups. 
The mean lifespan of wildtype (N2) on control diet was 17.2 +/- 0.52. The mean lifespan 
of wildtype worms on RNAi GFP diet was 16.77 +/- 0.39. The mean lifespan of the 
mutant strain (ATGL-1::GFP) on control and RNAi GFP diet was 21.03 +/- 0.85 days 
and 15.01 +/- 0.38 days, respectively. Maximum lifespan for the strains were 26, 25, 33, 
and 26 days respectively. 
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Figure 3: Experiment #2 Percent survival of N2 and ATGL-1 control and 
experimental groups. 
The mean lifespan of wildtype (N2) on control diet was 14.54 +/- 0.85 days. The mean 
lifespan of wildtype worms on RNAi GFP diet was 15.22 +/- 0.4 days. The mean lifespan 
of the mutant strain (ATGL-1::GFP) on control and RNAi GFP diet was 20.18 +/- 0.78 
days and 15.6 +/- 0.42 days, respectively. Maximum lifespan for the strains were 21, 22, 
30, and 24 days, respectively. 
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Figure 4: Day 2 Fluorescent microscopy analysis of all strains 
All images were taken from same day samples under the same exposure time. 
Measurement of GFP fluorescence of each strain were taken under the indicated 
condition on day 2 of the experiment.
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Figure 5: Day 14 Fluorescent microscopy analysis of all strains 
All images were taken from same day samples under the same exposure time. 
Measurement of GFP fluorescence of each strain was taken under the indicated condition 
on day 14 of the experiment.
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Figure 6: Day 22 Fluorescent microscopy analysis of all strains 
All images were taken from same day samples under the same exposure time. 
Measurement of GFP fluorescence of each strain were taken under the indicated 
condition on day 22 of the experiment.  
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DISCUSSION 
 
 As this experiment has shown, overexpression of ATGL-1 increases longevity in 
C. elegans. C. elegans are a model organism for studying metabolic diseases. The 
lipolytic pathway in mammals is evolutionary conserved in C. elegans in a simplified 
schematic as shown in Figure 2. During lipolysis, FoxO1 activates ATGL (ATGL-1) 
expression, and when ATGL is active, triglyceride stores are broken down. Conversely, 
when the insulin signaling pathway is active, Daf-2  (the insulin receptor) inhibits Daf-16 
(FoxO1) and therefore suppresses ATGL-1 (ATGL) expression, reducing rates of 
lipolysis. It has been well established that caloric restriction can increase longevity and 
lower mortality rates. Here, we mimic the effects of caloric restriction by using worms 
that overexpress ATGL-1. Overexpression of ATGL-1 increases rates of lipolysis and 
should theoretically increase lifespan. 
 Using RNAi, we downregulate GFP expression which was successfully 
demonstrated in Figures 4, 5, and 6. Results indicate that GFP downregulation shortens 
lifespan of ATGL-1::GFP worms to the length of that observed in N2 worms. It has been 
discussed the possibility that ATGL-1 acts as a dimer and when GFP is downregulated, 
the levels of ATGL-1 are reduced. Meaning that if ATGL-1 is acting as a dimer, when we 
downregulate GFP in ATGL-1::GFP, then only endogenous levels of ATGL-1 are 
contributing to the overall expression of ATGL-1 and that is why we see shortened 
lifespan in the ATGL-1::GFP worms on RNAi GFP bacteria. It could be one explanation 
as to why GFP downregulation seemed to have shortened the lifespan of ATGL-1::GFP 
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worms. Possibly, the dimer works in a system of cooperative binding where the 
downregulation of GFP decreases ATGL-1 binding affinity and expression. 
 It is also worth mentioning there was contamination of a few plates in both 
experiment 1 and 2 resulting in loss of experimental worms. However, these worms were 
censored during the experiment and taken into account during statistical analysis. 
Nevertheless, in experiment 1 this contamination resulted in a smaller starting N for both 
ATGL-1::GFP groups.  
 RNAi is not a 100% reliable technique, and there can be variation in the levels of 
downregulation of the specific gene of interest26. It was expected that there would be a 
difference between the levels of GFP expressed in ATGL-1::GFP worms on RNAi GFP 
bacteria between the two experiments and that the mean lifespans would not be exactly 
the same both times.  
It has been previously researched that the number of progeny of C. elegans may 
negatively correlate to longevity15.  During experimental conditions, it was observed and 
noted that ATGL-1::GFP strains laid visually less eggs than N2 strains. It was also noted 
that ATGL-1::GFP strains reached maturation and stopped laying eggs altogether sooner 
than N2 strains. Throughout the experiment, I observed a difference in the number of 
eggs within the ATGL-1::GFP strain, but the number of eggs was not quantified so it 
cannot be determined if this number was significantly different. Future studies can aim to 
examine the effects of ATGL-1 over-expression and reproductivity/egg number in 
longevity experiments. If egg laying correlates with longevity, then it is possible that the 
mechanism of which ATGL-1 increase longevity is through productivity. Our follow up 
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studies will be examining the use of RNAi to knockdown ATGL-1 and monitor effects on 
lifespan as well as to find out the mechanism in which ATGL increases lifespan.  
	21 
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